Although its yet to be released, early trials of retatrutide have shown that this new, innovative technology has helped people lose weight in a shorter amount of time than they have using the previous generation of injections, which include Zepbound and Wegovy
Given the rising prevalence of childhood obesity and Food and Drug Administration (FDA) approval of these medications after the age of 12 in the United States, this trend of increased use is not surprising, but access and usage of these medications vary widely
For women of childbearing potential, note that GLP-1 medications for weight management are contraindicated during pregnancy, and some agents should be discontinued at least two months before planned conception
This is important because while a large number of immune cells in the gut are activated by GLP-1 very few immune cells containing GLP-1 receptors are present in other organs
Format & Handling Supplied in sterile laboratory glass vials containing lyophilized peptide material